Attached files
| file | filename |
|---|---|
| EX-5.1 - OPINION ON LEGALITY - VistaGen Therapeutics, Inc. | ex5-1.htm |
| EX-4.1 - FORM OF WARRANT - VistaGen Therapeutics, Inc. | ex4-1.htm |
| EX-1.1 - FORM OF UNDERWRITING AGREEMENT - VistaGen Therapeutics, Inc. | ex1-1.htm |
| S-1/A - S-1/A - VistaGen Therapeutics, Inc. | vtgns1am12017.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We
hereby consent to the use, in the Prospectus constituting a part of
this Registration Statement (No. 333-221009) on Form S-1/A, Pre-Effective
Amendment No. 1, of our report dated June 29, 2017 (which report
expresses an unqualified opinion and includes an explanatory
paragraph expressing substantial doubt about the Company’s
ability to continue as a going concern) relating to the
consolidated financial statements of VistaGen Therapeutics, Inc.,
which is contained in Part II of the Registration
Statement.
We also
consent to the reference to us under the caption “Experts” in
the Prospectus.
/s/ OUM
& CO. LLP
San
Francisco, California
December
7, 2017